Literature DB >> 28290101

123I-mIBG and the phantom tollbooth.

Albert Flotats1,2,3, Ignasi Carrió4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28290101     DOI： 10.1007/s12350-017-0843-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  9 in total

1.  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.

Authors:  Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Mitsuhiro Yoshita; Junichi Taki; Masahito Yamada; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

2.  Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study.

Authors:  Hein J Verberne; Christel Feenstra; W Matthijs de Jong; G Aernout Somsen; Berthe L F van Eck-Smit; Ellinor Busemann Sokole
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05-18       Impact factor: 9.236

3.  How to use myocardial 123I-MIBG scintigraphy in chronic heart failure.

Authors:  Denis Agostini; Ignasi Carrio; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 9.236

4.  Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology.

Authors:  Albert Flotats; Ignasi Carrió; Denis Agostini; Dominique Le Guludec; Claudio Marcassa; Michael Schäfers; Michael Schaffers; G Aernout Somsen; Mustafa Unlu; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

5.  Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice.

Authors:  A A Dobbeleir; A S Hambÿe; P R Franken
Journal:  Eur J Nucl Med       Date:  1999-06

6.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

7.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.

Authors:  Kenichi Nakajima; Kosuke Matsubara; Takehiro Ishikawa; Nobutoku Motomura; Ryo Maeda; Nasima Akhter; Koichi Okuda; Junichi Taki; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

8.  A European myocardial 123I-mIBG cross-calibration phantom study.

Authors:  Derk O Verschure; Edwin Poel; Kenichi Nakajima; Koichi Okuda; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2017-01-24       Impact factor: 5.952

9.  Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations.

Authors:  Kenichi Nakajima; Koichi Okuda; Mana Yoshimura; Shinro Matsuo; Hiroshi Wakabayashi; Yasuhiro Imanishi; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.